Genetic Test Categorization System Proposed By SACGT Working Group
This article was originally published in The Gray Sheet
Executive Summary
Predictive genetic tests for disease with no proven intervention available would need heightened scrutiny under a two-tier oversight process proposed at an Aug. 4 meeting of HHS Secretary's Advisory Committee on Genetic Testing in Bethesda, Maryland.
You may also be interested in...
Rare Disease Genetic Tests Would Get Heightened Scrutiny In Altered Model
Genetic tests for rare diseases would receive a high level of scrutiny under a revised draft model endorsed for further evaluation by the HHS Secretary's Advisory Committee on Genetic Testing Nov. 3.
Genetic Testing Informed Consent White Paper Will Be Requested By SACGT
The HHS Secretary's Advisory Committee on Genetic Testing plans to commission a "white paper" to address variations in informed consent requirements for different types of genetic tests.
Rare Disease Genetic Tests Would Get Heightened Scrutiny In Altered Model
Genetic tests for rare diseases would receive a high level of scrutiny under a revised draft model endorsed for further evaluation by the HHS Secretary's Advisory Committee on Genetic Testing Nov. 3.